Rothschild & Co SCA
F:13F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rothschild & Co SCA
F:13F
|
FR |
|
Dr Reddy's Laboratories Ltd
NYSE:RDY
|
IN |
|
Covivio Hotels SCA
F:9FM
|
FR |
|
F
|
Federal Home Loan Mortgage Corp
XBER:FHL
|
US |
|
Raia Drogasil SA
BOVESPA:RADL3
|
BR |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
M
|
McCormick & Company Inc
BMV:MKCV
|
US |
|
MaxCyte Inc
F:MYE0
|
US |
|
U
|
United Natural Foods Inc
XBER:UN3
|
US |
|
N
|
Naturgy Energy Group SA
XMUN:GAN
|
ES |
|
T
|
Toshiba Corp
XHAM:TSE1
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 13F's stock price target?
Not Available
13F does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Rothschild & Co SCA?
Projected CAGR
-3%
Over the last 4 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 2 years is -3%.
What is the Net Income forecast for Rothschild & Co SCA?
Projected CAGR
-12%
Over the last 4 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is -12%.